Ainos (NASDAQ:AIMD) Stock Price Up 0.5% – What’s Next?

Ainos, Inc. (NASDAQ:AIMD) traded up 0.5% during trading on Friday . The company traded as high as $1.99 and last traded at $1.92. 20,799 shares changed hands during trading, a decline of 97% from the average session volume of 718,317 shares. The stock had previously closed at $1.91.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on AIMD shares. Wall Street Zen raised shares of Ainos from a “sell” rating to a “hold” rating in a research report on Friday, September 5th. Weiss Ratings restated a “sell (d-)” rating on shares of Ainos in a report on Monday. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock currently has an average rating of “Sell”.

Ainos Stock Up 0.5%

The business’s fifty day moving average price is $3.36 and its two-hundred day moving average price is $3.14. The company has a debt-to-equity ratio of 0.96, a quick ratio of 2.61 and a current ratio of 2.88. The firm has a market capitalization of $9.24 million, a P/E ratio of -0.38 and a beta of 2.22.

Ainos (NASDAQ:AIMD) last posted its earnings results on Thursday, November 13th. The company reported ($0.64) EPS for the quarter. The company had revenue of $0.00 million for the quarter.

Insider Activity at Ainos

In related news, major shareholder Carbon Nano Technology Taiwan sold 7,000 shares of the business’s stock in a transaction on Monday, October 6th. The stock was sold at an average price of $3.59, for a total transaction of $25,130.00. Following the transaction, the insider directly owned 1,037,206 shares in the company, valued at $3,723,569.54. The trade was a 0.67% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 9.79% of the company’s stock.

Institutional Investors Weigh In On Ainos

An institutional investor recently bought a new position in Ainos stock. Two Sigma Investments LP purchased a new position in shares of Ainos, Inc. (NASDAQ:AIMD) during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 23,008 shares of the company’s stock, valued at approximately $80,000. Two Sigma Investments LP owned about 0.48% of Ainos as of its most recent filing with the Securities & Exchange Commission.

Ainos Company Profile

Ainos, Inc, a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos’ cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a’s broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan.